Raúl Ortíz - Concepedia

Author

Raúl Ortíz

Also Known As

Consolación Melguizo, Laura Cabeza, Ortiz, R., Ortiz, Raul, Ortiz, Raúl, R Ortiz, R. Ortiz, Rachel Ortiz, Rafael Señeriz Ortiz, Raul Ortiz

165

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Universidad de Granada Instituto de Investigación Biosanitaria de Granada Universidad de Jaén Hospital Universitario Virgen de las Nieves University of Almería

About

Raúl Ortíz is an author at Universidad de Granada specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	512
2	Engineering	8	8	494
3	Biomedical Engineering	6	6	405
4	Health Sciences	1	1	26
5	Allergy	1	1	29

Raúl Ortíz

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression Gloria Perazzoli, José Prados, Raúl Ortíz, PLoS ONE	2015	187
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications Raúl Ortíz, Gloria Perazzoli, Laura Cabeza, Current Neuropharmacology Nanotechnology AdvancesEngineeringBiomedical EngineeringHigh-grade GliomasGlioma	2020	161
Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer Beatriz Clares, Rafael A. Biedma-Ortiz, E Sáez-Fernández, European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesNanomedicineFerrofluidEngineeringNanomaterials	2013	94
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy Consolación Melguizo, José Prados, Beatríz González, Journal of Translational Medicine	2012	80
Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells Cristiano Farace, Jaime Antonio Oliver, Consolación Melguizo, PLoS ONE	2015	61
Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study Laura Cabeza, Raúl Ortíz, José Prados, European Journal of Pharmaceutical Sciences NanoparticlesNanomedicineOncologyAntitumor ActivityEngineering	2017	54
A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer Julia Jiménez-López, Mazen M. El‐Hammadi, Raúl Ortíz, Pharmacological Research NanomedicineEngineeringVivo Ptx ActivityPolymer-drug ConjugateNano-drug Delivery	2019	53
Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes Julia Jiménez-López, Inmaculada Bravo‐Caparrós, Laura Cabeza, Biomedicine & Pharmacotherapy	2020	51
Magnetically active pNIPAM nanosystems as temperature-sensitive biocompatible structures for controlled drug delivery Beatriz García-Pinel, Alicia Ortega-Rodríguez, Cristina Porras-Alcalá, Artificial Cells Nanomedicine and Biotechnology	2020	48
Oxaliplatin–Biomimetic Magnetic Nanoparticle Assemblies for Colon Cancer-Targeted Chemotherapy: An In Vitro Study Ylenia Jabalera, Beatriz García-Pinel, Raúl Ortíz, Pharmaceutics NanoparticlesNanomedicineColon Cancer-targeted ChemotherapyConventional ChemotherapyEngineering	2019	47

Page 1